Gain Therapeutics (GANX) Current Taxes (2020 - 2026)

Gain Therapeutics has reported Current Taxes for 7 years, with the latest figure at $69689.0 in Q2 2026.

• On a quarterly basis, Current Taxes rose 176.88% year-over-year to $69689.0 in Q2 2026; TTM through Jun 2026 was $69689.0, a 176.88% increase from a year earlier, with the FY2025 full-year figure at $43089.0, up 133.0% from the prior year.
• Current Taxes was $69689.0 for Q2 2026 at Gain Therapeutics, up from $66674.0 in the prior quarter.
• The five-year high for Current Taxes was $184693.0 in Q2 2023, with the low at $2035.0 in Q1 2022.
• Average Current Taxes over 5 years is $54930.1, with a median of $47627.0 recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Current Taxes jumped 28139.74% in 2022, then plunged 75.93% in 2025.
• Over 5 years, Current Taxes stood at $107311.0 in 2022, then plunged by 54.37% to $48965.0 in 2023, then plunged by 62.23% to $18493.0 in 2024, then soared by 133.0% to $43089.0 in 2025, then soared by 61.73% to $69689.0 in 2026.
• The last three Current Taxes figures came in at $69689.0 (Q2 2026), $66674.0 (Q1 2026), and $43089.0 (Q4 2025), per Business Quant data.